Mimedx (MDXG) Depreciation & Amortization (CF) (2011 - 2026)

Mimedx (MDXG) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 49.52% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $13.3 million (up 68.16% YoY), and the FY2025 full-year result was $14.9 million, up 146.33% from the prior year.
• Depreciation & Amortization (CF) slipped to $1.6 million in Q1 2026, from $3.2 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.3 million in Q3 2025 to a low of $558000.0 in Q1 2024.
• A 5-year average of $1.6 million and a median of $858000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) surged 474.01% in 2025 and slumped 49.52% in 2026, its largest moves.
• Tracing MDXG's Depreciation & Amortization (CF) over 5 years: stood at $796000.0 in 2022, then slipped by 23.24% to $611000.0 in 2023, then soared by 389.36% to $3.0 million in 2024, then climbed by 7.69% to $3.2 million in 2025, then slumped by 49.78% to $1.6 million in 2026.
• Business Quant data shows MDXG's Depreciation & Amortization (CF) at $1.6 million in Q1 2026, $3.2 million in Q4 2025, and $5.3 million in Q3 2025.